CHRONIC MYELOID LEUKEMIA, CHRONIC PHASE
Clinical trials for CHRONIC MYELOID LEUKEMIA, CHRONIC PHASE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOID LEUKEMIA, CHRONIC PHASE trials appear
Sign up with your email to follow new studies for CHRONIC MYELOID LEUKEMIA, CHRONIC PHASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for leukemia patients: daily pill trial launches
Disease control Recruiting nowThis study tests a new daily pill, TERN-701, for adults with chronic myeloid leukemia (CML) whose cancer has not responded well to or caused side effects from other treatments. The trial has two parts: first finding the safest dose, then testing that dose in more people to see ho…
Matched conditions: CHRONIC MYELOID LEUKEMIA, CHRONIC PHASE
Phase: PHASE1, PHASE2 • Sponsor: Terns, Inc. • Aim: Disease control
Last updated May 26, 2026 09:39 UTC
-
New CML drug combo aims for deeper remission without lifelong side effects
Disease control Recruiting nowThis study tests a new drug called asciminib as the first treatment for adults newly diagnosed with chronic myeloid leukemia (CML). If the drug doesn't work well enough after up to 3 years, patients can also get a low dose of another standard drug. The goal is to see if this appr…
Matched conditions: CHRONIC MYELOID LEUKEMIA, CHRONIC PHASE
Phase: PHASE2 • Sponsor: Augusta University • Aim: Disease control
Last updated May 26, 2026 09:33 UTC
-
New hope for CML patients: drug combo aims for Drug-Free remission
Disease control Recruiting nowThis study tests whether adding asciminib to standard tyrosine kinase inhibitors (TKIs) can help people with chronic myeloid leukemia (CML) safely stop all medication and stay in remission. It includes 69 adults who have been on TKIs for at least 5 years and previously failed to …
Matched conditions: CHRONIC MYELOID LEUKEMIA, CHRONIC PHASE
Phase: PHASE2 • Sponsor: Korean Society of Hematology • Aim: Disease control
Last updated May 22, 2026 13:52 UTC